Hubei Goto Biopharm Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 385.04 million compared to CNY 446.82 million a year ago. Revenue was CNY 385.04 million compared to CNY 446.82 million a year ago.

Net income was CNY 22.78 million compared to CNY 39.92 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.35 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.35 a year ago.